Qual é o preço para Novo Nordisk A/S (NOVO-B)

O preço para Novo Nordisk A/S (NOVO-B) é $43.92

Qual é a capitalização de mercado para Novo Nordisk A/S (NOVO-B)

A capitalização de mercado para Novo Nordisk A/S (NOVO-B) é $195.10B

Novo Nordisk A/S (NOVO-B) Desdobramentos de Ações

Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.

Ano	Desdobramento	Multiplicador	Multiplicador cumulativo
2023-09-13	2:1	x2	x20
2014-01-02	5:1	x5	x10
2008-01-25	2:1	x2	x2

Ano

Desdobramento

Multiplicador

Multiplicador cumulativo

2023-09-13

2:1

x20

2014-01-02

5:1

x10

2008-01-25

2:1

Empresa	Número de desdobramentos de ações	Multiplicador cumulativo	País
Eli Lilly and Company LLY.US	4	x15	US
Johnson & Johnson JNJ.US	7	x432	US
AbbVie Inc. ABBV.US	0	-	US
Roche Holding AG RO.SW	2	x10000	CH
Merck & Co., Inc. MRK.US	7	x226	US

Empresa

Número de desdobramentos de ações

Multiplicador cumulativo

País